MoonLake Immunotherapeutics presents positive 12-week data from the Phase 2 MIRA trial with ...

MoonLake Immunotherapeutics presents positive 12-week data from the

Related Keywords

Switzerland ,Hidradenitis Suppurativa ,Patricia Sousa ,Namrata Taak ,Kristian Reich ,Matthias Bodenstedt ,Mary Jane Elliott ,Moonlake Immunotherapeutics ,Ashley Tapp ,Exchange Commission ,International Hidradenitis Suppurativa Severity Score System ,American College Of Rheumatology Conference ,Venereology Congress ,European Academy Of Dermatology ,European Academy ,Chief Scientific Officer ,American College ,Rheumatology Conference ,Hidradenitis Suppurativa Clinical Response ,Dermatology Life Quality Index ,Numerical Rating Scale ,Global Assessment ,Skin Pain ,Global Assessment Score ,Psoriasis Area ,Severity Index ,Securities Litigation Reform Act ,Annual Report ,Jane Elliott ,Business ,